Showing 1 - 12 results of 12 for search 'Rick A Vreman', 查询时间: 0.04s Refine Results
  1. 1
    Getting the Right Evidence After Drug Approval

    Getting the Right Evidence After Drug Approval 由 Rick A. Vreman, Rick A. Vreman, Hubert G. M. Leufkens, Aaron S. Kesselheim

    出版 2020-09-01
    获取全文
    文件
  2. 2
    Real World Data in Health Technology Assessment of Complex Health Technologies

    Real World Data in Health Technology Assessment of Complex Health Technologies 由 Milou A. Hogervorst, Milou A. Hogervorst, Johan Pontén, Rick A. Vreman, Rick A. Vreman, Aukje K. Mantel-Teeuwisse, Wim G. Goettsch, Wim G. Goettsch

    出版 2022-02-01
    获取全文
    文件
  3. 3
    Regulatory reliance pathways during health emergencies: enabling timely authorizations for COVID-19 vaccines in Latin America

    Regulatory reliance pathways during health emergencies: enabling timely authorizations for COVID-19 vaccines in Latin America 由 Ivar T. van der Zee, Rick A. Vreman, Lawrence Liberti, Mario Alanis Garza

    出版 2022-08-01
    获取全文
    文件
  4. 4
    Delayed payment schemes in Central-Eastern Europe and Middle-East

    Delayed payment schemes in Central-Eastern Europe and Middle-East 由 Ildikó Ádám, Marcelien Callenbach, Bertalan Németh, Rick A. Vreman, Rick A. Vreman, Johan Pontén, Tea Strbad, Dalia Dawoud, Alexander Kostyuk, Ahmed Seyam, László Nagy, Wim G. Goettsch, Wim G. Goettsch, Zoltán Kaló, Zoltán Kaló

    出版 2022-08-01
    获取全文
    文件
  5. 5
    Bridging the gap: Can International Consortium of Health Outcomes Measurement standard sets align outcomes accepted for regulatory and health technology assessment decision‐making of oncology medicines

    Bridging the gap: Can International Consortium of Health Outcomes Measurement standard sets align outcomes accepted for regulatory and health technology assessment decision‐making... 由 Rachel R. J. Kalf, Rick A. Vreman, Diana M.J. Delnoij, Marcel L. Bouvy, Wim G. Goettsch

    出版 2021-04-01
    获取全文
    文件
  6. 6
    Increasing the information provided by probabilistic sensitivity analysis: The relative density plot

    Increasing the information provided by probabilistic sensitivity analysis: The relative density plot 由 Joost W. Geenen, Rick A. Vreman, Cornelis Boersma, Olaf H. Klungel, Anke M. Hövels, Renske M. T. Ten Ham

    出版 2020-11-01
    获取全文
    文件
  7. 7
    Tools for assessing quality of studies investigating health interventions using real-world data: a literature review and content analysis

    Tools for assessing quality of studies investigating health interventions using real-world data: a literature review and content analysis 由 Aukje K Mantel-Teeuwisse, Rick A Vreman, Olaf H Klungel, Junfeng Wang, Li Jiu, Michiel Hartog, Wim G Goettsch

    出版 2024-02-01
    获取全文
    文件
  8. 8
    Synergy between health technology assessments and clinical guidelines for multiple sclerosis

    Synergy between health technology assessments and clinical guidelines for multiple sclerosis 由 Milou A. Hogervorst, Rick A. Vreman, Anna Zawada, Magdalena Zielińska, Dalia M. Dawoud, Brigit A. deJong, Aukje K. Mantel‐Teeuwisse, Wim G. Goettsch

    出版 2023-05-01
    获取全文
    文件
  9. 9
    Perspectives on how to build bridges between regulation, health technology assessment and clinical guideline development: a qualitative focus group study with European experts

    Perspectives on how to build bridges between regulation, health technology assessment and clinical guideline development: a qualitative focus group study with European experts 由 Marie Louise De Bruin, Aukje Mantel-Teeuwisse, Hubert G M Leufkens, Rick A Vreman, Junfeng Wang, Wim Goettsch, Milou A Hogervorst, Mathias Møllebæk, Ting-An Lu

    出版 2023-08-01
    获取全文
    文件
  10. 10
    The Role of Regulator-Imposed Post-Approval Studies in Health Technology Assessments for Conditionally Approved Drugs

    The Role of Regulator-Imposed Post-Approval Studies in Health Technology Assessments for Conditionally Approved Drugs 由 Rick A. Vreman, Lourens T. Bloem, Stijn van Oirschot, Jarno Hoekman, Menno E. van der Elst, Hubert GM Leufkens, Olaf H. Klungel, Wim G. Goettsch, Aukje K. Mantel-Teeuwisse

    出版 2022-05-01
    获取全文
    文件
  11. 11
    Outcome-based reimbursement in Central-Eastern Europe and Middle-East

    Outcome-based reimbursement in Central-Eastern Europe and Middle-East 由 Ildikó Ádám, Marcelien Callenbach, Bertalan Németh, Rick A. Vreman, Rick A. Vreman, Cecilia Tollin, Johan Pontén, Dalia Dawoud, Dalia Dawoud, Jamie Elvidge, Nick Crabb, Sahar Barjesteh van Waalwijk van Doorn-Khosrovani, Anke Pisters-van Roy, Áron Vincziczki, Emad Almomani, Maja Vajagic, Z. Gulsen Oner, Mirna Matni, Jurij Fürst, Rabia Kahveci, Wim G. Goettsch, Wim G. Goettsch, Zoltán Kaló, Zoltán Kaló

    出版 2022-09-01
    获取全文
    文件
  12. 12
    Associations between uncertainties identified by the European Medicines Agency and national decision making on reimbursement by HTA agencies

    Associations between uncertainties identified by the European Medicines Agency and national decision making on reimbursement by HTA agencies 由 Lourens T. Bloem, Rick A. Vreman, Niels W. L. Peeters, Jarno Hoekman, Menno E. van derElst, Hubert G. M. Leufkens, Olaf H. Klungel, Wim G. Goettsch, Aukje K. Mantel‐Teeuwisse

    出版 2021-07-01
    获取全文
    文件

检索工具: